Abstract
Surgical septal myectomy is the preferred method of septal reduction for most patients with obstructive hypertrophic cardiomyopathy whose symptoms do not respond to medical management. Transaortic extended septal myectomy has low operative mortality and provides durable relief of symptoms. Surgical treatment is possible for patients with less common phenotypes, such as complex long-segment septal hypertrophy, midventricular obstruction, or apical hypertrophic cardiomyopathy. For these anatomic subtypes, transapical myectomy can be used alone or combined with transaortic myectomy. This article describes both of these surgical techniques and discusses preoperative considerations and postoperative management for patients with hypertrophic cardiomyopathy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 95-104 |
| Number of pages | 10 |
| Journal | Cardiology Clinics |
| Volume | 37 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 1 2019 |
Fingerprint
Keywords
- Hypertrophic cardiomyopathy
- Septal myectomy
- Transaortic
- Transapical
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Surgical Myectomy : Subaortic, Midventricular, and Apical. / Nguyen, Anita; Schaff, Hartzell V.
In: Cardiology Clinics, Vol. 37, No. 1, 01.02.2019, p. 95-104.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Surgical Myectomy
T2 - Subaortic, Midventricular, and Apical
AU - Nguyen, Anita
AU - Schaff, Hartzell V
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Surgical septal myectomy is the preferred method of septal reduction for most patients with obstructive hypertrophic cardiomyopathy whose symptoms do not respond to medical management. Transaortic extended septal myectomy has low operative mortality and provides durable relief of symptoms. Surgical treatment is possible for patients with less common phenotypes, such as complex long-segment septal hypertrophy, midventricular obstruction, or apical hypertrophic cardiomyopathy. For these anatomic subtypes, transapical myectomy can be used alone or combined with transaortic myectomy. This article describes both of these surgical techniques and discusses preoperative considerations and postoperative management for patients with hypertrophic cardiomyopathy.
AB - Surgical septal myectomy is the preferred method of septal reduction for most patients with obstructive hypertrophic cardiomyopathy whose symptoms do not respond to medical management. Transaortic extended septal myectomy has low operative mortality and provides durable relief of symptoms. Surgical treatment is possible for patients with less common phenotypes, such as complex long-segment septal hypertrophy, midventricular obstruction, or apical hypertrophic cardiomyopathy. For these anatomic subtypes, transapical myectomy can be used alone or combined with transaortic myectomy. This article describes both of these surgical techniques and discusses preoperative considerations and postoperative management for patients with hypertrophic cardiomyopathy.
KW - Hypertrophic cardiomyopathy
KW - Septal myectomy
KW - Transaortic
KW - Transapical
UR - http://www.scopus.com/inward/record.url?scp=85055744008&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055744008&partnerID=8YFLogxK
U2 - 10.1016/j.ccl.2018.08.006
DO - 10.1016/j.ccl.2018.08.006
M3 - Review article
VL - 37
SP - 95
EP - 104
JO - Cardiology Clinics
JF - Cardiology Clinics
SN - 0733-8651
IS - 1
ER -